<DOC>
	<DOCNO>NCT01359826</DOCNO>
	<brief_summary>Systemic lupus erythematosus ( SLE ) chronic multi-system autoimmune disease impact physical , social , psychological health quality life patient . Fatigue pain aspect SLE patient affect health relate quality life ( HRQOL ) . The purpose study determine effect milnacipran fatigue SLE patient widespread pain ( WSP ) fibromyalgia syndrome ( FMS ) . A secondary objective determine effect milnacipran pain quality life measurement . Fifty SLE male female patient , 18 year old , recruit 15-week study , patient receive 14 week milnacipran 50-100 mg twice day placebo . Measurements fatigue , pain , HRQOL compare milnacipran placebo group screen visit , baseline visit , week number 6 , week number 14 . Milnacipran show effective treatment pain , fatigue physical function FMS patient . To date , clinical trial demonstrate efficacy treatment fatigue SLE patient concomitant WSP FMS . The investigator hypothesize , base FMS study , milnacipran treat patient less fatigue placebo group . In addition , compare control arm , treat study drug less pain improved quality life .</brief_summary>
	<brief_title>The Effect Milnacipran Fatigue Quality Life Lupus Patients</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>Female male age 18 older . Has fulfil 1997 classification criterion SLE . Has chronic WSP FMS . Score 40 visual analog score ( VAS ) fatigue . Has chronic inflammatory autoimmune condition SLE . Has acute uncontrolled comorbid medical condition . Uncontrolled narrow angle glaucoma . Has hospitalize last four month lupus flare . Pregnant breast feeding . Has current prior major depressive disorder DSM IV diagnosis within 2 year screen visit . The use antidepressant , MAO inhibitor , antipsychotic lithium The use pregabalin milnacipran within 24 week . Has receive cyclophosphamide rituximab within 4 6 month . Unable speak , read , understand English .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Systemic Lupus Erythematosus</keyword>
	<keyword>Widespread Pain</keyword>
	<keyword>Fibromyalgia</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Pain</keyword>
	<keyword>Quality Life</keyword>
</DOC>